Hair restoration

• Causes of Alopecia
  • Androgenetic alopecia (male/female pattern hair loss)
  • Telogen effluvium (stress, illness, hormones)
  • Alopecia areata (autoimmune)
  • Traction alopecia (hairstyles)
  • Nutritional deficiencies (e.g., iron, vitamin D, biotin)

• Common Mechanisms in Hair Loss
  • DHT (dihydrotestosterone) sensitivity
  • Inflammation of follicles
  • Reduced blood flow to scalp
  • Oxidative stress and hormonal imbalance

• Ingredient Overview (Topical & Oral)
  • Finasteride / Dutasteride (DHT blockers)
  • Minoxidil (vasodilator)
  • Spironolactone (anti-androgen for females)
  • Tretinoin (increases follicular absorption)
  • Fluocinolone (anti-inflammatory steroid)
  • Latanoprost / Bimatoprost (prostaglandin analogs for growth)
  • Biotin (supports keratin infrastructure)
  • Caffeine (improves follicle stimulation)
  • Cetirizine (antihistamine with anti-inflammatory role)

Condition Type	Recommended Formula(s)	Rationale
Male Androgenetic Alopecia	A16, A19, A20, A22	Targets DHT with finasteride + minoxidil for regrowth support
Female Androgenetic Alopecia	A24, A25, A19	Anti-androgens (spironolactone), DHT blockers, and biotin for female pattern loss
Early Thinning (Mild Loss)	A23, A19	Lightweight stimulation using minoxidil, caffeine, and biotin for early cases
Scalp Inflammation with Hair Loss	A20, A21 (cetirizine), A24 (spironolactone)	Formulas include anti-inflammatories like fluocinolone and cetirizine to calm scalp
Postpartum Shedding	A25, A24	Hormone-friendly options with spironolactone and biotin for postpartum needs
Telogen Effluvium (Stress/Illness-Related)	A23, A25	Non-hormonal support (biotin, caffeine) ideal for stress-induced shedding
Autoimmune-Linked Hair Loss (Alopecia Areata)	A21, A24	Anti-inflammatory and anti-androgenic action supports autoimmune-related shedding
DHT-Sensitive Hairline or Vertex Loss	A16, A19, A21	Strong DHT blockers like finasteride/dutasteride plus minoxidil for pattern loss areas
Patients Needing Non-Hormonal Support	A23, A19	Biotin and caffeine-based formulas avoid systemic hormone blockers
Patients Needing Oral Support (Male)	A22	Combines systemic DHT blockade with follicle support nutrients
Patients Needing Oral Support (Female)	A25	Combines non-androgenic support with minoxidil and spironolactone for females

• Timeline of Expected Results
  • 0–4 Weeks:
  • Expected initial shedding as older hairs are pushed out to make way for new growth
  • Patients may worry it's worsening—reassure them this is normal
  • 4–12 Weeks:
    • Shedding typically stabilizes
    • Shedding typically stabilizes
  • 3–6 Months:
    • Increased hair density becomes more noticeable
    • Texture and coverage improve
  • 6–12 Months:
    • Maximum improvement for most patients
    • Continued use maintains gains

PATIENCE AND ADHERENCE ARE KEY!

• Side Effects to Monitor
  • Topical irritation (redness, dryness, itching)
  • Systemic effects (finasteride/dutasteride: libido changes, mood)
  • Spironolactone: breast tenderness, irregular menses (females)
  • Minoxidil: shedding initially (expected behavior), rare hypotension
  • Allergies: Biotin, caffeine (rare)

• Drug-Drug Interactions to Monitor
  • Finasteride / Dutasteride (5-alpha reductase inhibitors)
  • Caution with other drugs that affect hormone levels (e.g., testosterone therapy, corticosteroids)
  • May alter PSA (prostate-specific antigen) results—important for prostate cancer monitoring
  • Spironolactone (anti-androgen) *A25 capsules
  • Risk of hyperkalemia (high potassium) when combined with:
  • ACE inhibitors (e.g., lisinopril)
  • ARBs (e.g., losartan)
  • Potassium-sparing diuretics
  • May interact with digoxin or lithium
  • Minoxidil (vasodilator) *A22 and A25 capsules
  • Oral minoxidil: caution with blood pressure medication—can cause additive hypotension (low blood pressure)

• Drug-Disease Interactions to Monitor
  • Finasteride: *A22 capsules
    • Use with caution in patients with a history of liver disease (hepatically metabolized)
  • Spironolactone: *A25 capsules
    • Caution in kidney disease or hyperkalemia (high potassium levels)
    • Monitor electrolytes and kidney function regularly (inform kidney doctor if on capsules containing spironolactone)
  • Minoxidil: *A22 and A25 capsules
    • Oral: use cautiously in patients with cardiovascular disease (inform cardiologist if on capsules containing minoxidil)